Table 4.
Estimated crude and age-standardized cancer mortality rates by sex during 2024 in Korea
| Site | Crude mortality rates per 100,000 |
Age-standardized mortality rates per 100,000a) |
||||
|---|---|---|---|---|---|---|
| Both sexes | Men | Women | Both sexes | Men | Women | |
| All sites | 163.2 | 199.0 | 127.8 | 60.8 | 83.8 | 43.3 |
| Lip, oral cavity, and pharynx | 2.5 | 3.6 | 1.4 | 1.0 | 1.6 | 0.5 |
| Esophagus | 2.9 | 5.1 | 0.6 | 1.1 | 2.2 | 0.2 |
| Stomach | 12.3 | 15.9 | 8.6 | 4.8 | 7.0 | 3.0 |
| Colon and rectum | 17.1 | 19.0 | 15.1 | 6.1 | 8.2 | 4.4 |
| Liverb) | 17.8 | 26.0 | 9.7 | 6.8 | 11.4 | 2.9 |
| Gallbladderc) | 11.2 | 12.1 | 10.2 | 3.7 | 4.9 | 2.7 |
| Pancreas | 15.3 | 15.7 | 15.0 | 5.6 | 6.7 | 4.7 |
| Larynx | 0.4 | 0.7 | 0.0 | 0.1 | 0.3 | 0.0 |
| Lungd) | 35.6 | 53.0 | 18.4 | 12.3 | 21.1 | 5.5 |
| Breast | 5.9 | 0.1 | 11.7 | 2.9 | 0.0 | 5.8 |
| Cervix uteri | 1.4 | - | 2.7 | 0.7 | - | 1.3 |
| Corpus uteri | 0.9 | - | 1.8 | 0.4 | - | 0.8 |
| Ovary | 2.9 | - | 5.7 | 1.3 | - | 2.5 |
| Prostate | 4.9 | 9.8 | - | 1.4 | 3.7 | - |
| Testis | 0.0 | 0.1 | - | 0.0 | 0.1 | - |
| Kidney | 2.1 | 2.8 | 1.4 | 0.8 | 1.2 | 0.4 |
| Bladder | 3.2 | 4.9 | 1.6 | 1.0 | 1.9 | 0.4 |
| Brain and CNS | 3.0 | 3.3 | 2.6 | 1.6 | 1.9 | 1.3 |
| Thyroid | 0.7 | 0.4 | 0.9 | 0.2 | 0.2 | 0.2 |
| Hodgkin lymphoma | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 |
| Non-Hodgkin lymphoma | 4.9 | 5.6 | 4.2 | 1.8 | 2.4 | 1.3 |
| Multiple myeloma | 2.2 | 2.2 | 2.1 | 0.8 | 0.9 | 0.7 |
| Leukemia | 4.4 | 5.1 | 3.6 | 1.9 | 2.4 | 1.4 |
| Other and ill defined | 11.9 | 13.3 | 10.4 | 4.5 | 6.0 | 3.4 |
CNS, central nervous system.
a)
Age adjusted to the world standard population,
b)
Includes the liver and intrahepatic bile duct,
c)
Includes the gallbladder and other/unspecified parts of the biliary tract,
d)
Includes the lung and bronchus.